Some recently introduced drugs.
D000578:Amidines / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D003005:Clopamide / Q000627:therapeutic use; D004358:Drug Therapy; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D006016:Glycolates / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D010423:Pentazocine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D011410:Propanidid / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000578:Amidines; D000900:Anti-Bacterial Agents; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D006016:Glycolates; D007211:Indoles; D003473:Neuromuscular Nondepolarizing Agents; D011804:Quinolines; D013565:Sympatholytics; D003005:Clopamide; D011239:Prednisolone; D011410:Propanidid; D014700:Verapamil; D011299:Prenylamine; D004976:Ethacrynic Acid; D010400:Penicillin G; D010423:Pentazocine; D012293:Rifampin